About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Active Not RecruitingPhase 4

Atorvastatin Effect on Reduction of COPD Exacerbations

Non-commercial Clinical Trial of Statins CAncer Preventive and Pleiotropic TherApy IN Smokers With Chronic Obstructive Pulmonary Disease (COPD)

NCT04789057•Medical University of Bialystok

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

CopdCOPD ExacerbationSmoking+2 more

Interventions

Atorvastatin 40 Mg Oral Tablet

Placebo

Locations

1

Poland

Locations (1)

Medical University Hospital

Bialystok, Poland

Key Dates

Start Date

February 11, 2022

Primary Completion Date

December 31, 2026

Completion Date

May 31, 2027

Last Updated

April 21, 2026

Related Studies

Cigarette Filter Study

NCT07348679

Smoking ( Cigarette)

Study of Patient With Frequent Exacerbations in Moscow

NCT07307781

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease and Asthma in Workers at Navanakorn Industrial Zone, Thailand

NCT07383896

RECRUITINGPhase 2

Cannabidiol for Reducing Cigarette Use

NCT06218056

Tobacco Use DisorderTobacco Smoking+1 more

RECRUITINGPhase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT06598397

Human Immunodeficiency Virus (HIV)Smoking Cessation

Additional Effects of Box Breathing Technique With Short Term Pulmonary Rehabilitation on Dyspnea and Functional Capacity in Patients With Chronic Obstructive Pulmonary Disease

NCT07518472

Pulmonary Disease, Chronic Obstructive (COPD)

View all related studies

Sponsors

Lead Sponsor

Medical University of Bialystok

Collaborators

Medical Research Agency, Poland

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 21, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions